Skip to content
Clinical Trials – home

Mitral valve incompetence Life with Disease

1 / 2 trials open to patients2 countries

In short

Mitral valve incompetence, also known as mitral regurgitation, occurs when the mitral valve in your heart doesn't close properly, allowing blood to leak backward. While many people live with mild forms without knowing it, understanding this condition and its progression can help you and your family prepare for the journey ahead.

Key points

  • Mitral valve incompetence affects people differently—some live symptom-free for decades while others need prompt treatment, making regular monitoring with your cardiologist essential.
  • Even if you feel completely well, severe regurgitation can silently damage your heart, which is why the timing of treatment matters as much as the treatment itself.
  • Modern surgical repair techniques achieve success rates exceeding 99% at specialized centers, with very low mortality rates, making valve repair preferable to replacement in most cases.
  • Your heart compensates remarkably well in early stages, but this adaptation has limits—symptoms often appear only after years of silent progression and significant heart changes.
  • Complications like heart failure, atrial fibrillation, and stroke risk increase as the condition worsens, but timely intervention can prevent these serious outcomes.
  • Lifestyle modifications matter—managing salt intake, staying as active as possible within your limits, and monitoring weight changes help manage symptoms and maintain quality of life.
  • Family support makes a real difference, especially in helping navigate treatment decisions, attending appointments, and exploring options like clinical trials that might offer innovative solutions.
  • Medications can't fix the valve but they're crucial for managing symptoms, reducing heart strain, and preventing complications while you're being monitored or awaiting treatment.

Understanding What to Expect: Prognosis

When someone receives a diagnosis of mitral valve incompetence, one of the first questions that comes to mind is what the future holds. The outlook for this condition varies greatly depending on how severe the valve leak is and how quickly it's addressed. For many people with mild mitral regurgitation, life can continue much as before, with regular monitoring but no immediate need for intervention. The heart often compensates well for minor leaks, and you may not experience symptoms for years or even decades.

However, the picture changes when the regurgitation becomes moderate to severe. Research shows that severe mitral regurgitation significantly affects long-term survival if left untreated. Studies have demonstrated that the greater the severity of the leak—measured through specialized heart imaging tests—the higher the frequency of serious heart-related events, even in people who initially have no symptoms and normal heart function. This means that even if you feel fine today, a severely leaking valve can silently place stress on your heart over time.

The good news is that modern treatment options, particularly surgical valve repair, have dramatically improved outcomes for people with this condition. Mitral valve repair is now considered one of the most effective long-term treatments, offering patients an excellent probability for a safe and lasting solution. Centers specializing in this surgery report repair rates exceeding 99 percent for certain types of mitral valve disease, with very low mortality rates of less than 1 percent. These numbers represent a significant achievement in cardiac care and offer hope to those facing this diagnosis.

Age and other heart conditions also influence prognosis. People over 50 years old with severe regurgitation, those who develop an irregular heartbeat called atrial fibrillation (a condition where the heart beats irregularly and often rapidly), or those with enlargement of the left atrium face higher risks of complications. The presence of symptoms such as shortness of breath or extreme fatigue also indicates a more urgent need for treatment and closer monitoring.

Natural Progression Without Treatment

Understanding how mitral valve incompetence develops and worsens over time helps you recognize why early monitoring matters so much. In many cases, this condition begins very gradually. The valve tissue may slowly weaken due to a process called myxomatous degeneration, where the valve becomes too stretchy and floppy. Alternatively, conditions like rheumatic heart disease (damage from untreated strep throat infections) or hardening of the valve tissue can cause the problem to develop over many years.

When left untreated, chronic mitral regurgitation follows a predictable but variable course. In the early stages, your heart compensates remarkably well for the leaking valve. The left ventricle—the main pumping chamber of your heart—gradually enlarges and works harder to pump enough blood forward to your body, despite the blood leaking backward with each heartbeat. During this compensation phase, you may feel completely normal and have no idea anything is wrong.

Over time, however, this extra work takes its toll. The left ventricle can become overstretched and weakened, losing its ability to pump effectively. This is when symptoms typically begin to appear. You might notice shortness of breath during activities that never bothered you before, or you may wake up at night feeling like you can't catch your breath. Some people notice their ankles swelling or feel exhausted after minimal exertion.

As the condition advances without treatment, the left atrium—the upper chamber of your heart that receives blood from your lungs—also enlarges from the extra blood flowing back into it. This enlargement increases your risk of developing atrial fibrillation, an irregular heart rhythm that can cause palpitations and further reduce your heart's efficiency. The pressure from blood backing up into the lungs can lead to pulmonary hypertension (high blood pressure in the lungs), making breathing even more difficult.

The timeline of progression varies significantly from person to person. Some people with moderate regurgitation remain stable for many years, while others experience rapid deterioration. Factors that influence how quickly the condition worsens include the underlying cause of the valve problem, your age, other heart conditions you may have, and your overall health status. This unpredictability is why regular monitoring with echocardiography—a test using sound waves to create pictures of your heart—is so important.

Possible Complications

Mitral valve incompetence can lead to several serious complications that extend beyond the valve itself. Understanding these potential problems helps you recognize warning signs and seek prompt medical attention when needed. The most common complication is heart failure, a condition where your heart can no longer pump enough blood to meet your body's needs. This doesn't mean your heart stops beating, but rather that it becomes progressively weaker and less efficient.

Heart failure from mitral regurgitation develops when the constant extra workload finally overwhelms your heart muscle. The left ventricle stretches and weakens, unable to maintain the increased pumping effort required. When this happens, fluid backs up into your lungs, causing difficulty breathing, persistent coughing (especially when lying down), and severe fatigue. In advanced cases, fluid can also accumulate in your legs, ankles, and abdomen, causing uncomfortable swelling.

Atrial fibrillation represents another significant complication. When the left atrium enlarges from the backflow of blood, its electrical system becomes disrupted, leading to rapid, chaotic heartbeats. Atrial fibrillation not only causes uncomfortable palpitations and increased fatigue but also dramatically increases your risk of stroke. Blood can pool and clot in the irregularly beating atrium, and these clots can travel to your brain, blocking blood flow and causing a stroke.

Infective endocarditis, an infection of the heart valve, poses a particular risk for people with damaged or abnormal valves. Bacteria entering your bloodstream during dental procedures, medical procedures, or even from everyday activities can settle on the damaged valve and cause a serious infection. This complication requires prolonged antibiotic treatment and can further damage the valve, sometimes necessitating emergency surgery.

Less commonly, people with severe untreated mitral regurgitation may experience dangerous heart rhythm disturbances originating from the ventricles, which can potentially lead to sudden cardiac death. The ongoing strain on the heart muscle creates areas of electrical instability that can trigger these life-threatening rhythms. Additionally, the chronic elevation of pressure in the blood vessels of your lungs can lead to permanent pulmonary hypertension, which adds another burden to your heart and further limits your ability to breathe comfortably.

Impact on Daily Life

Living with mitral valve incompetence affects people in different ways depending on the severity of their condition. For those with mild regurgitation, daily life often continues without interruption. You may not even know you have the condition until a doctor hears a heart murmur—an unusual whooshing sound caused by the blood leaking backward—during a routine examination. Many people with mild cases maintain their normal activity levels, continue working, pursue hobbies, and live independently without significant limitations.

As the condition progresses to moderate or severe levels, the impact on daily activities becomes more noticeable. Physical activities that once felt effortless may leave you breathless and exhausted. Simple tasks like climbing stairs, carrying groceries, or walking to your mailbox can become challenging. You might find yourself avoiding activities you once enjoyed because the shortness of breath or fatigue makes them unpleasant or even frightening. This gradual reduction in activity can be particularly difficult emotionally, as it may feel like your independence is slipping away.

Sleep disturbances commonly affect people with advancing mitral regurgitation. You may wake up an hour or two after falling asleep feeling like you're suffocating, needing to sit upright or prop yourself up with multiple pillows to breathe comfortably. This condition, called orthopnea (difficulty breathing when lying flat), occurs because when you lie down, fluid that has accumulated in your legs during the day redistributes to your lungs, making breathing harder. Poor sleep quality compounds fatigue during the day, creating a cycle that significantly impacts your quality of life.

Emotional and psychological effects can be substantial. Living with a chronic heart condition brings worry about the future, anxiety about sudden worsening of symptoms, and concern about becoming a burden to loved ones. Some people experience depression, particularly when physical limitations prevent them from participating in social activities or pursuing careers. The unpredictable nature of symptoms—feeling reasonably well one day and exhausted the next—can make planning difficult and add to feelings of frustration.

Work life may require adjustments as your condition progresses. Jobs requiring physical exertion become increasingly difficult. Even sedentary work can be challenging if you're experiencing severe fatigue. Some people need to reduce their hours, change to less demanding positions, or even stop working earlier than planned. These changes can have significant financial implications and affect your sense of purpose and identity.

Relationships with family and friends often change as well. You may need to decline invitations to activities you can no longer manage, which can lead to social isolation. Partners and family members may take on caregiving roles, shifting the dynamics of your relationships. Open communication about your capabilities, limitations, and needs becomes crucial for maintaining healthy connections with the people who matter most to you.

Despite these challenges, many people find ways to adapt and maintain meaningful lives. Regular exercise within your limitations—such as gentle walking or swimming—can help maintain strength and stamina. Learning to pace yourself, taking rest breaks, and prioritizing activities that matter most to you allows you to conserve energy for what brings you joy. Working closely with your healthcare team to manage symptoms through medications and lifestyle adjustments can help you maintain the best possible quality of life while awaiting or recovering from treatment.

Support for Family: Understanding Clinical Trials

For families facing mitral valve incompetence, understanding clinical trials and how they might benefit your loved one represents an important part of comprehensive care. Clinical trials are research studies that test new treatments, procedures, or devices before they become widely available. For mitral valve disease, these trials might investigate new surgical techniques, minimally invasive repair methods, or innovative devices to treat the leaking valve.

Researchers at major medical centers are continuously working to improve outcomes for people with mitral valve incompetence. Current clinical trials may focus on less invasive ways to repair valves, new imaging techniques to better assess valve function, or medications that might slow the progression of the disease. Some trials test devices that can repair valves through small tubes inserted into blood vessels, avoiding the need for open-heart surgery. These transcatheter procedures (treatments performed through a small tube inserted into a blood vessel) represent a rapidly evolving field that may offer hope to patients who cannot tolerate traditional surgery.

Family members can play a crucial role in helping their loved one explore clinical trial opportunities. Start by having an open conversation with the patient's cardiologist or cardiac surgeon about whether clinical trials might be appropriate. Not every patient is a candidate for every trial—researchers have specific criteria about who can participate based on the severity of valve disease, other health conditions, age, and many other factors. Your doctor can help determine whether any current trials match your loved one's situation.

Helping with research and information gathering represents another valuable way families can support trial participation. You can search for clinical trials through websites that list current studies, though the sources provided for this article focus primarily on general information about the condition rather than specific trial listings. Your loved one's medical team typically has the most current information about trials being conducted at their institution or nearby centers.

If your family member decides to consider a clinical trial, help them prepare for the initial screening and evaluation process. This often involves additional tests and appointments to determine eligibility. You can assist by organizing medical records, creating a list of all current medications, documenting symptoms and how they affect daily activities, and writing down questions to ask the research team. Having this information readily available makes the evaluation process smoother and ensures nothing important gets overlooked.

Understanding the commitment required for trial participation helps families plan accordingly. Clinical trials typically require more frequent visits to the medical center than standard care would involve. There may be additional testing, careful monitoring, and detailed follow-up appointments over months or even years. Transportation to and from appointments, time away from work, and the emotional energy required for participation can be substantial. Discussing these practical considerations as a family before enrolling helps everyone prepare.

Supporting someone through trial participation also means being prepared for uncertainty. In some trials, patients are randomly assigned to receive either the new treatment or the standard treatment—neither the patient nor the doctors choose which group they're in. This can be emotionally challenging, but it's necessary for determining whether new treatments truly work better than existing ones. Your role as a family member includes helping your loved one cope with this uncertainty and reinforcing that their participation contributes valuable knowledge that may help future patients.

Keep in mind that clinical trial participation isn't the right choice for everyone, and standard treatment options have excellent success rates for many patients with mitral valve incompetence. The decision about whether to pursue a trial should be made carefully, with input from the patient's medical team, consideration of personal values and preferences, and realistic assessment of what participation would mean for the patient and family. Your support in helping your loved one gather information, weigh options, and make an informed decision represents one of the most valuable things you can do.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Diuretics (water pills) – Help remove excess fluid from the lungs and body, reducing swelling and breathlessness caused by fluid buildup
  • Beta-blockers – Medications that help control heart rate and reduce strain on the heart
  • ACE inhibitors – Help reduce the strain on the heart by lowering blood pressure and making it easier for blood to flow
  • Calcium channel blockers – Help control blood pressure and reduce the workload on the heart
  • Anticoagulants (blood thinners) – Help prevent blood clots in people who have developed atrial fibrillation due to mitral valve disease
  • Antibiotics – May be prescribed before certain dental or medical procedures to prevent heart valve infections in patients who have had valve replacement

Did you know?

  1. Mitral valve regurgitation is the most common type of heart valve disease in the United States and the second most frequent indication for valve surgery in Europe.
  2. A past use of the diet pill "Fen-Phen" (fenfluramine and phentermine), which was removed from the market by the FDA in 1997, remains a risk factor for developing mitral valve regurgitation even decades later.
  3. Some top medical centers report mitral valve repair rates exceeding 99 percent for degenerative mitral valve disease, making replacement increasingly rare when surgery is performed by experienced specialists.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Mitral valve incompetence

Recruiting trials first

See all 2 trials →
Quick filters

2 clinical trials in this condition

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Heparin Sodium
  • Sponsor:Agencja Badań Medycznych
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Sacubitril
  • Sponsor:Ziekenhuis Oost Limburg
See all 2 trials →filters applied: condition = Mitral valve incompetence

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).